← Back to headlines
Pfizer Wins FDA Approval for Padcev-Keytruda Combination in Bladder Cancer
Pfizer has received FDA label expansion for its drug Padcev when used in combination with Merck’s Keytruda for the treatment of bladder cancer.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
